Furthermore, we chose several EZH2 or LSD1 potential targets (P15, P21, LATS1, LATS2, RND1, KLF2, E-cadherin, PTEN, ASPP2 and RRAD) with tumor-suppressor function, and hypothesized that they may involve in the contributions of AGAP2-AS1 to NSCLC progression. The gene discussed is KDM1A; the disease is non-small cell lung carcinoma.